Skip to main content
TradingNews

Market news

Eli Lilly Crushes Q2 Earnings, Mounjaro Sales Soar 91%

24/7 Wall St. Read original source (opens in a new tab)
The Story

News Summary

  • Eli Lilly (LLY) posted a blowout Q2 with 27% EPS beat and 91% Mounjaro growth, raising full-year guidance.
  • Not a directly tracked symbol, but as a major S&P 500 component, strong results provide mild support to broader index sentiment.
Explore US500 price history & advisor snapshot

These are separate market snapshots and may predate this story. Check the data period, generation time and expiry before using them in your research.

Stored market data

US500 price history

7578.32 +11.24% over the displayed period

Advisor Snapshot

Unlock Member-Only Insights

Reserved for TradingNews24 members. Log in or create a free account to access market signals and exclusive tools.

Open US500 advisor →
Browse August 2026 news → ← Back to market news

Market analysis for educational use. Trading involves risk. AI sentiment is not financial advice.

Methodology · Risk disclosure